SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.85-0.7%Dec 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (24468)8/13/1998 4:51:00 PM
From: J Stone  Read Replies (1) of 32384
 
Henry,

As I stated earlier, I believe LGND liked SRGN's production facilities. Correct me if I'm wrong, but if LGND hopes to sell Targretin and Panretin for off-label usage the rights to which I believe are not owned by LLY et al, then SRGN's production facilities become more important because LGND can make their own drugs for sale rather than having to resell drugs produced by LLY for them.

This production capability would be consistent with the addition of salespeople.

Jeff
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext